Whitland/Carmarthenshire, Wales, U.K.) over the left dorsolateral prefrontal cortex. The intensity was 110% of the motor threshold, the frequency 25 Hz, 20 trains per session, 50 pulses per each train the duration of each train was 2 seconds followed by an interval of 28 seconds. Safety criteria reported by Wasserman 1 were exceeded because another study by our group 2 and our unpublished data on 178 patients (O.T., A.C., N.T., et al., [2004] [2005] [2006] ) exceeding these criteria have produced satisfactory and safe results.
Scores on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) by rTMS sessions are shown in Table 1 and Figure 1 . After the 15th session, the diagnosis of pregnancy was made. Forty-seven days had passed after the menstruation. She had been strictly prohibited from getting pregnant for many years because of aggressive and continuous pharmacotherapy, and she had reported that she had been using an effective form of birth control. Before rTMS, a pregnancy test had not been administered, because only 2 weeks had passed after the last menstruation. The patient did not report the delay of the expected menstruation because she ignored it since she sometimes experienced menstruation delay. She preferred to continue pregnancy, stop medications, and receive rTMS following informed consent. She was also under close obstetric follow-up. Neither maternal nor fetal complication occurred during pregnancy.
Four days after the 58th session, she gave birth to a healthy girl, at the term, in early 2005. The baby weighed 3200 g and was 49 cm tall. Complete physical and neurologic examination, screening tests for phenylketonuria and hypothyroidism, and hearing assessment of the newborn revealed no abnormalities. The newborn did not have congenital hip dysplasia, congenital cardiac disease, cleft lip, or cleft palate. There were no gastrointestinal, pulmonary, or muscular abnormalities. Twenty days later, we restarted rTMS to prevent depression relapse. She continued lactation.
Ms. A responded (response defined as a 50% decrease in HAM-D-17 score) to rTMS at the end of the 50th session (6 months after beginning rTMS, with rTMS given in varying intervals). She attained remission (remission defined as a HAM-D-17 score below 8) at the end of the 68th session, approximately 1 year after beginning rTMS. No seizure or other significant side effect occurred.
Although depression remitted with rTMS, since panic disorder was aggravated, the patient began treatment with fluoxetine (which was increased to 80 mg daily) once she stopped lactating 8 months after the delivery.
The patient received 35 sessions of rTMS in the first trimester, 15 sessions in the second trimester, 8 sessions in the third trimester (for a total of 58 sessions during the pregnancy), and 19 sessions during 7.5 months after the delivery. Depression was still in remission 22 months after the delivery. Panic disorder, followed up with no clinical scale, decreased during pregnancy and postpartum 6 months, but then recurred.
The child's physical development and neurologic development were normal through 22 months; there was no diagnosis of disease, except a viral upper respiratory infection lasting a few days.
rTMS has been shown to be useful in the treatment of depression. [4] [5] [6] [7] [8] [9] [10] A pregnant woman receiving rTMS in the second trimester has been reported in another study. 11 Our patient received rTMS in all trimesters.
Varying of intervals between rTMS sessions was due to the patient's request and also regarding the literature reporting that daily stimulation is not essential. [12] [13] [14] It seems that although rTMS is effective, a greater number of sessions or sessions of longer durations than those reported in previous studies are needed to produce significant results. On the other hand, rTMS given at intervals may be useful to improve and maintain the mood. 11, 12 Furthermore, even if rTMS is not useful in the acute treatment, improvement in mood may be observed a few months later. 12 Although the fact that response and remission took nearly a year is more consistent with the natural history of depression than with a therapeutic response to rTMS, our patient's history of depression had tended to follow a chronic and recurrent course in that she had received pharmacotherapy and psychotherapy for a long time and underwent ECT without any significant recovery except during her first planned pregnancy and lactation. It may be suspected that pregnancy itself might have resulted in remission of depressive symptoms. However, contrary to clinical lore, pregnancy is not always a time of emotional well-being; pregnant and nonpregnant women have similar rates of depression. 15 Furthermore, our patient's first pregnancy had not resulted in remission; on the contrary, her first pregnancy was a planned pregnancy that occurred after remission, and depression subsequently recurred during lactation.
Finally, a few studies have employed rTMS in a small number of patients with panic disorder. 16, 17 It seems that rTMS parameters given in depression may not prevent relapses in panic disorder. 
Tardive Dystonia and Ziprasidone: A Case Report
Sir: Ziprasidone is an atypical antipsychotic with higher affinity for human serotonin-2A (5-HT 2A ) receptors than dopamine-2 (D 2 ) receptors. It is reported to have minimal extrapyramidal side effects similar to that of placebo. 1 However, there are reports of acute dystonia with ziprasidone.
2,3 A MEDLINE/PubMed search using keywords dystonia and ziprasidone revealed no published reports of tardive dystonia with ziprasidone.
Case report. Mr. A, a 25-year-old unmarried man who had graduated from university and hailed from an urban middle class socioeconomic background, reported to our institute in 2005. On evaluation, he had family history of obsessivecompulsive disorder in his mother and dysthymia in his father. There was no significant past psychiatric/medical history or personal history. His premorbid personality had been well adjusted. Mr. A presented with an insidious-onset continuous illness of 2.5 years' duration that was characterized by delusions of persecution, delusions of reference, third-person auditory hallucinations, and second-person command hallucinations. He was diagnosed with schizophrenia, paranoid subtype (per DSM-IV). Treatment with ziprasidone, 40 mg initially and slowly increased to 120 mg/day, led to reduction of positive symptoms. However, he reported sedation and mild tremors of the hand (there was no bradykinesia or rigidity) without impairment in his daily routine activities during follow-up.
Three months later, he presented with 4 to 6 weeks' history of inability to stand upright, being bent to the left, and a mildto-moderate degree of pain in the thoracic area, which was continuous in nature and caused significant emotional distress. Examination showed dystonic scoliosis of the thoracic spine with convexity to the right. No other muscle group was involved. The above clinical presentation satisfies the diagnostic criteria for tardive dystonia set forth by Burke et al. in 1982. 4 This truncal dystonia was impairing his daily activities as well as his social and occupational functioning. No concomitant medication was given during this period. There was no family history of similar abnormal movement disorder, nor was there a history of any substance use or trauma.
The ziprasidone dose was initially reduced to 80 mg/day. The dystonia did not improve, hence ziprasidone was further reduced to 40 mg/day and diazepam 10 to 20 mg/day was added during his sixth month of follow-up. During his seventh month of follow-up, the patient reported obsessive ruminations, obsessive doubts, compulsive checking, fleeting delusions, and elementary auditory hallucinations. Since there was worsening of schizophrenia symptoms, emergence of obsessive-compulsive symptoms, and no improvement in dystonia, he was admitted for evaluation and treatment. On examination, he had truncal dystonia, mild perioral-buccal-lingual dyskinesia, and postural tremors of hand (left > right). Neurologic opinion was taken. Liver and kidney function tests, including workup for Wilson's disease, were performed along with a magnetic resonance imaging scan of the brain. However, findings of all of the above investigations were within normal limits. Thus, the treating team decided to taper and stop ziprasidone 40 mg/day over a period of 6 days, and at the same time, clozapine was initiated, which was slowly increased to 300 mg/day for psychotic symptoms, along with escitalopram 20 mg/day for his obsessivecompulsive symptoms. During 2 months of treatment with these medications, tardive dystonia was reduced substantially, along with reduction of obsessive-compulsive symptoms.
PSYCHIATRIST.COM Although ziprasidone is a new atypical antipsychotic with reported low potential for extrapyramidal side effects, 1 it may cause tardive dystonia. The patient in our case was young and male, both of which carry some risk factors. However, it is difficult to speculate about the contribution of family history of obsessive-compulsive disorder and dysthymia and the presentation of the schizo-obsessive-compulsive type in the etiopathogenesis of tardive dystonia. A remote possibility is that obsessive-compulsive disorder occurs because of basal ganglia dysfunction, and prescribing high doses of antipsychotics in schizophrenia with obsessive-compulsive symptoms may cause tardive dystonia. We recommend that clinicians be cautious in prescribing ziprasidone, especially in young male patients presenting with schizophrenia with obsessive-compulsive symptoms. Sir: Separation anxiety disorder refers typically to younger children who are extremely unwilling to separate from major attachment figures (e.g., parents, grandparents, older siblings) or from home.
1 Separation anxiety disorder can dramatically affect a child's life and his parent's life by limiting the ability to engage in ordinary activities, for example, regular school attendance due to excessive worry about potential harm toward oneself or one's primary caregivers. School refusal is reported in about 75% of children with separation anxiety disorder, and vice versa, separation anxiety disorder is reported in about 80% of children with school refusal. 2 Furthermore, studies show that school refusal is significantly associated with anxiety and affective disorders. 3 However, only few data suggest that separation anxiety disorder is a risk factor for developing psychiatric disorders when children grow up. 4 To evaluate this hypothesis, we reexamined 10 school refusers who had been treated for separation anxiety disorder for ongoing school refusal, separation anxiety disorder, and further psychiatric disorders.
Method. Five male and 5 female former school refusers with separation anxiety disorder, who had been treated for 12 weeks with cognitive-behavioral therapy at the Department of Child and Adolescent Psychiatry of Innsbruck Medical University, Austria, were followed up until summer 2006. Follow-up assessment was conducted between 2 to 8 years (mean = 4.4 years) after their discharge. At follow-up, children were aged 9 to 14 years (mean age = 12.7 years) and lived in a community setting. History of separation anxiety disorder and school attendance were assessed in an interview with the patient and a parent. Separation anxiety disorder and other psychiatric disorders were evaluated with the children's version of the Diagnostic Interview for Mental Disorders in Children and Adolescents, 5 a standardized lifetime diagnostic interview of psychiatric syndromes for children and adolescents according to DSM-IV diagnostic criteria, which is an expanded German version of the Anxiety Disorders Interview Schedule. Results. Persisting symptoms of school refusal were only seen in 1 boy. However, all children presented at least 2 psychiatric disorders, 1 of them presented 3, 2 of them presented 4, and 2 of them presented 5, with some psychiatric disorders in partial remission, including separation anxiety disorder. Psychiatric disorders that were found are attention-deficit/ hyperactivity disorder (N = 6), oppositional defiant disorder (N = 4), conduct disorder (N = 1), major depressive disorder (N = 1), social phobia (N = 1), specific phobia (N = 3), panic disorder with agoraphobia (N = 3), obsessive-compulsive disorder (N = 3), and specific developmental disorders of scholastic skills (N = 2). Two children were rated with functional enuresis in complete remission.
At follow-up examination, all 10 subjects met DSM-IV criteria for at least 2 psychiatric disorders. Only 1 of 10 patients had persistent separation anxiety disorder. Three patients were fully remitted, whereas 6 patients were in partial remission of separation anxiety disorder. These results support the hypothesis that school refusers with separation anxiety disorder are at high risk for developing subsequent mental disorders. Further research should also clarify whether separation anxiety disorder is a specific risk factor for other anxiety disorders, or whether separation anxiety disorder in children is a general factor of vulnerability for a broad range of psychiatric disorders. 2, 7 In conclusion, clinicians have to be aware that school refusers with separation anxiety disorder are predisposed for developing distinct psychiatric disorders and probably require further treatment even after remission of separation anxiety disorder.
Using Functional Behavioral Assessment to Study the Effects of Citalopram on the Obsessive-Compulsive Verbalizations of a Woman With Obsessive-Compulsive Disorder and Mental Retardation
Sir: Obsessive-compulsive disorder (OCD) is an anxiety disorder characterized by repetitive thoughts and/or ritualistic behaviors.
1 Approximately 2% to 3% of the general population is diagnosed with OCD, with children more likely to be diagnosed than adults. 2 People with OCD often experience diminished functioning in school, work, or community contexts, particularly in relation to social relationships.
One common observation made by investigators studying OCD is that behaviors associated with this disorder are often exacerbated by stressful social situations. 3 This observation suggests that OCD-related behaviors can be sensitive to social reinforcers. However, such social situations often confound a variety of socially mediated reinforcers and contingencies, and no assessment methodology has been successful in identifying operant functions associated with OCD-related behaviors.
Given the usefulness of functional behavioral assessment in treating the behavioral problems of other populations, 4 there may be some utility to incorporating such an approach into the assessment of OCD-related behaviors. 5 The focus of such assessments is to identify the types of operant functions associated with the problem behavior. A first step in conducting a functional behavioral assessment of OCD-related behaviors is the development of a protocol for distinguishing between different types of operant functions (e.g., positive vs. negative reinforcement). 6, 7 In the current investigation, we used an analogue functional analysis procedure to assess the obsessive-compulsive verbalizations of a woman with OCD and mental retardation. Our goal was to use 2 common forms of social reinforcement 8, 9 that might maintain the obsessive-compulsive verbalizations and then study the effects of a selective serotonin reuptake inhibitor, citalopram, on the obsessive-compulsive verbalizations.
Case report. Ms. A, a 49-year-old woman, was dually diagnosed in 2006 with OCD and mild mental retardation. The OCD diagnosis was made on the basis of DSM-IV criteria. Her specific behaviors relating to her OCD diagnosis were derived from clinical interviews. Ms. A struggled with a great deal of anxiety that appeared to have increased since the death of her husband. She reported fears consistent with OCD obsessions (e.g., "I don't go to the second floor because I'm afraid I might jump out," "I don't go to funerals because I'm afraid I might jump in the hole," and "I don't like to drive by water because my staff might drown me"). She voiced contamination fears, reporting she felt the need to wash her hands after shaking hands with others and that she preferred to avoid this contact altogether. She had other generalized anxieties, such as becoming quite anxious if watching scary movies.
Her psychiatrist referred her to the Vanderbilt University Behavior Analysis Clinic to determine if obsessive-compulsive verbalizations had an environmental (social) component. All sessions were conducted in the living room of her home. Prior to baseline, her daily medication regimen was stabilized at clonazepam (1 mg), haloperidol (150 mg q. month), quetiapine fumarate (50 mg), and valproic acid (500 mg). No changes were made in these medications for the duration of the study.
Obsessive-compulsive verbalizations were scored as frequency counts using a paper-and-pencil system. Two independent observers scored 100% of sessions. Interobserver agreement was estimated by dividing the smaller value by the larger and multiplying by 100%. Interobserver agreement was 100%. A combined A-B multielement design was used to study obsessive-compulsive verbalizations during an analogue functional analysis. 10 Four experimental conditions were analyzed within the multielement design. The first 2 conditions tested the positive reinforcer functions associated with attention. The positive reinforcement condition provided brief social interactions from a therapist when obsessive-compulsive verbalizations occurred. A second condition, negative punishment, reversed this reinforcement contingency by removing attention when obsessive-compulsive verbalizations occurred. 11 The second pair of conditions tested the negative reinforcer functions associated with demands. The negative reinforcement condition terminated requests by a therapist when obsessive-compulsive verbalizations occurred. The next condition, positive punishment, initiated requests by a therapist each time an obsessivecompulsive verbalization occurred.
Once a baseline pattern was established, we assessed the effects of citalopram on the obsessive-compulsive verbalizations under the same set of conditions. During the drug assessment, citalopram was titrated to 20 mg q.d. She received citalopram for 8 weeks before the functional behavioral assessment with citalopram was conducted.
From 2 to 5 sessions were completed per day, 2 to 4 times per week. Each session was 5 minutes in length with a 5-minute interval between sessions. During all sessions, 2 therapists were present. The first set of contingencies assessed the effects of social attention as positive reinforcement for the obsessivecompulsive verbalizations. 11 During positive reinforcement sessions, therapists were seated near the patient. No social interaction occurred. If the patient made an obsessive-compulsive verbalization, a therapist directed a social comment toward her (e.g., "Why are you scared of going to the doctor?"). During negative punishment sessions, therapists were seated near the patient and conversed with her every 5 to 10 seconds about non-OCD topics (e.g., "It is a sunny day today"). If an obsessivecompulsive verbalization was emitted, social interaction was terminated until no obsessive-compulsive verbalizations were emitted for 30 seconds. The second set of contingencies assessed the effects of escape from demands as negative reinforcement for obsessive-compulsive verbalizations. During negative reinforcement sessions, statements relating to her OCD topics were made every 30 seconds (e.g., "You need to go exercise at the YWCA this afternoon") (the YMCA had a pool in the facility). If an obsessive-compulsive verbalization was made, therapists ceased making statements until no obsessivecompulsive verbalization had been emitted during the previous 30 seconds. During positive punishment sessions, therapists were seated near the patient, but no social interaction occurred.
If an obsessive-compulsive verbalization occurred, a statement relating to her OCD topics was made by a therapist (e.g., "You have a doctor's visit tomorrow") (the doctor's office was on the second floor of a multistory building). The number of obsessive-compulsive verbalizations emitted during the analogue functional analysis conditions is shown in Figure 1 . No obsessive-compulsive verbalizations were emitted during the attention conditions. This finding suggests that she did not make obsessive-compulsive verbalizations to obtain social attention as positive reinforcement. During the negative reinforcement condition, obsessive-compulsive verbalizations were emitted a mean of 4.8 times (range, 2-11). During the positive punishment condition, only 1 obsessivecompulsive verbalization occurred. These data suggest that her obsessive-compulsive verbalizations were sensitive to negative reinforcement contingencies (i.e., escaping or avoiding stimuli). After establishing a baseline, citalopram was administered. No obsessive-compulsive verbalizations were observed in the attention conditions, similar to baseline. In the negative reinforcement condition, 3 obsessive-compulsive verbalizations were observed in the first session, but none afterward.
Our findings suggest that the obsessive-compulsive verbalizations of a woman dually diagnosed with OCD and mental retardation were sensitive to escape from demands, but not social attention. These findings are the first functional analysis of obsessive-compulsive verbalizations and suggest these verbalizations can serve a social reinforcement function. The administration of citalopram, against a baseline of other medications, reduced negatively reinforced obsessive-compulsive verbalizations, suggesting that citalopram may reduce the noxious properties of stimuli that the obsessive-compulsive verbalizations typically avoided or escaped.
The use of functional analyses was successful in identifying social reinforcers associated with the obsessive-compulsive verbalizations. The use of the same stimulus in relation to the same response, but under distinct contingency arrangements, may prove a useful approach that could improve the success of functional analysis outcomes. 12, 13 This technique is the first functional analysis of obsessive-compulsive verbalizations in a patient with OCD. Future research will be needed to know (a) if such an approach is necessary in analyzing OCD-related behaviors, (b) whether it is more efficacious than other functional behavioral assessment approaches, and (c) whether the differential contingency approach can be extended to other behaviors and populations of interest.
Our findings regarding citalopram need to be viewed as preliminary because of the single-case nature of this study and the other medications the patient was receiving. If replicated, these findings suggest that a functional approach to the assessment of OCD-related behaviors may yield some insight into the reasons these behaviors occur. In addition, this methodology may allow for a behavioral analysis of the effects of commonly prescribed psychotropic medications on behaviors of psychiatric interest.
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The authors report no other financial affiliation or relationship relevant to the subject of this letter. recommend venous thromboembolism prophylaxis in acutely ill medical patients such as those with congestive heart failure or severe respiratory disease or who are confined to bed with risk factors such as active cancer, previous venous thromboembolism, sepsis, acute neurologic disease, or inflammatory bowel disease. In addition to mechanical prophylaxis, unfractionated heparin and low-molecular-weight heparin are recommended for venous thromboembolism prophylaxis in this setting. An association between delirium tremens and deep vein thromboembolism has not been reported previously, and it is not usually considered a risk factor for deep vein thromboembolism. Thus, deep vein thromboembolism prophylaxis is not generally started when severe alcohol withdrawal is present. However, patients with delirium tremens typically present with multiple risk factors for deep vein thromboembolism, and further studies must be undertaken to determine guidelines for deep vein thromboembolism prophylaxis in these patients.
